Covan67
2021-12-01
🙏
After-Hours Stock Movers 11/30: (AMBA) (BOX) (ZS) Higher; (CTIC) (CRM) (IMGN) Lower (more...)
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":609495793,"tweetId":"609495793","gmtCreate":1638315843397,"gmtModify":1638315843533,"author":{"id":3574925228684475,"idStr":"3574925228684475","authorId":3574925228684475,"authorIdStr":"3574925228684475","name":"Covan67","avatar":"https://static.tigerbbs.com/bfbd7f4c5a941d77774de1196b34df5e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>🙏</p></body></html>","htmlText":"<html><head></head><body><p>🙏</p></body></html>","text":"🙏","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/609495793","repostId":2188532487,"repostType":2,"repost":{"id":"2188532487","kind":"news","pubTimestamp":1638312720,"share":"https://ttm.financial/m/news/2188532487?lang=&edition=full","pubTime":"2021-12-01 06:52","market":"us","language":"en","title":"After-Hours Stock Movers 11/30: (AMBA) (BOX) (ZS) Higher; (CTIC) (CRM) (IMGN) Lower (more...)","url":"https://stock-news.laohu8.com/highlight/detail?id=2188532487","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAmbarella 13.1% HIGHER; reported Q3 EPS of $0.57, $0.08 better than the an","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/AMBA\">Ambarella</a> 13.1% HIGHER; reported Q3 EPS of $0.57, $0.08 better than the analyst estimate of $0.49. Revenue for the quarter came in at $92.2 million versus the consensus estimate of $90.35 million. Ambarella sees Q4 2022 revenue of $88.5-91.5 million, versus the consensus of $88.22 million.</p>\n<p><a href=\"https://laohu8.com/S/CTIC\">CTI BioPharma</a> 12.4% LOWER; announced the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for pacritinib for the treatment of adult patients with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) with a baseline platelet count of <50 × 109/L. The Prescription Drug User Fee Act (PDUFA) action date has been extended by three months to February 28, 2022.</p>\n<p><a href=\"https://laohu8.com/S/BOX\">Box</a> 8.9% HIGHER; reported Q3 EPS of $0.22, $0.01 better than the analyst estimate of $0.21. Revenue for the quarter came in at $224 million versus the consensus estimate of $218.49 million. Box sees Q4 2022 EPS of $0.22-$0.23, versus the consensus of $0.22. Box sees Q4 2022 revenue of $227-229 million, versus the consensus of $222.93 million. Box sees FY2022 EPS of $0.83-$0.84, versus the consensus of $0.81. Box sees FY2022 revenue of $868-870 million, versus the consensus of $858.51 million.</p>\n<p><a href=\"https://laohu8.com/S/CRM\">Salesforce</a> 6% LOWER; reported Q3 EPS of $1.27, $0.35 better than the analyst estimate of $0.92. Revenue for the quarter came in at $6.86 billion versus the consensus estimate of $6.79 billion. Salesforce sees Q4 2022 EPS of $0.72-$0.73, versus the consensus of $0.81. Salesforce sees Q4 2022 revenue of $7.224-7.234 billion, versus the consensus of $7.22 billion.</p>\n<p><a href=\"https://laohu8.com/S/IMGN\">ImmunoGen</a> Inc. (Nasdaq: IMGN) 5.5% LOWER; intends to offer and sell, subject to market and other conditions, $175 million of shares of its common stock in an underwritten public offering.</p>\n<p><a href=\"https://laohu8.com/S/ZS\">Zscaler Inc.</a> 4.6% HIGHER; reported Q1 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $230.5 million versus the consensus estimate of $208.43 million. Zscaler sees Q2 2022 EPS of $0.11, versus the consensus of $0.12. Zscaler sees Q2 2022 revenue of $240-242 million, versus the consensus of $221.15 million. Zscaler sees FY2022 EPS of $0.50-$0.52, versus the consensus of $0.56. Zscaler sees FY2022 revenue of $1-1.01 billion, versus the consensus of $0.94156 billion.</p>\n<p><a href=\"https://laohu8.com/S/HPE\">Hewlett Packard Enterprise</a> 2.4% LOWER; reported Q4 EPS of $0.52, $0.03 better than the analyst estimate of $0.49. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $7.39 billion. Hewlett Packard Enterprise sees Q1 2022 EPS of $0.42-$0.50, versus the consensus of $0.49. Hewlett Packard Enterprise sees FY2022 EPS of $1.96-$2.10, versus the consensus of $2.03.</p>\n<p><a href=\"https://laohu8.com/S/NTAP\">NetApp</a> 1.2% HIGHER; reported Q2 EPS of $1.28, $0.07 better than the analyst estimate of $1.21. Revenue for the quarter came in at $1.57 billion versus the consensus estimate of $1.55 billion. NetApp sees Q3 2022 EPS of $1.21-$1.31, versus the consensus of $1.28. NetApp sees Q3 2022 revenue of $1.53-1.68 billion, versus the consensus of $1.59 billion. NetApp sees FY2022 EPS of $4.90-$5.10, versus the consensus of $5.01.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers 11/30: (AMBA) (BOX) (ZS) Higher; (CTIC) (CRM) (IMGN) Lower (more...)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers 11/30: (AMBA) (BOX) (ZS) Higher; (CTIC) (CRM) (IMGN) Lower (more...)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 06:52 GMT+8 <a href=https://www.streetinsider.com/dr/news.php?id=19291110><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAmbarella 13.1% HIGHER; reported Q3 EPS of $0.57, $0.08 better than the analyst estimate of $0.49. Revenue for the quarter came in at $92.2 million versus the consensus ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19291110\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4141":"半导体产品","BOX":"Box Inc","BK4139":"生物科技","ZS":"Zscaler Inc.","IMGN":"ImmunoGen","BK4535":"淡马锡持仓","BK4505":"高瓴资本持仓","AMBA":"安霸","BK4538":"云计算","CRM":"赛富时","BK4550":"红杉资本持仓","BK4548":"巴美列捷福持仓","CTIC":"CTI BIOPHARMA","BK4561":"索罗斯持仓","BK4097":"系统软件","BK4532":"文艺复兴科技持仓","BK4560":"网络安全概念","BK4527":"明星科技股"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19291110","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188532487","content_text":"After-Hours Stock Movers:\nAmbarella 13.1% HIGHER; reported Q3 EPS of $0.57, $0.08 better than the analyst estimate of $0.49. Revenue for the quarter came in at $92.2 million versus the consensus estimate of $90.35 million. Ambarella sees Q4 2022 revenue of $88.5-91.5 million, versus the consensus of $88.22 million.\nCTI BioPharma 12.4% LOWER; announced the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for pacritinib for the treatment of adult patients with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) with a baseline platelet count of <50 × 109/L. The Prescription Drug User Fee Act (PDUFA) action date has been extended by three months to February 28, 2022.\nBox 8.9% HIGHER; reported Q3 EPS of $0.22, $0.01 better than the analyst estimate of $0.21. Revenue for the quarter came in at $224 million versus the consensus estimate of $218.49 million. Box sees Q4 2022 EPS of $0.22-$0.23, versus the consensus of $0.22. Box sees Q4 2022 revenue of $227-229 million, versus the consensus of $222.93 million. Box sees FY2022 EPS of $0.83-$0.84, versus the consensus of $0.81. Box sees FY2022 revenue of $868-870 million, versus the consensus of $858.51 million.\nSalesforce 6% LOWER; reported Q3 EPS of $1.27, $0.35 better than the analyst estimate of $0.92. Revenue for the quarter came in at $6.86 billion versus the consensus estimate of $6.79 billion. Salesforce sees Q4 2022 EPS of $0.72-$0.73, versus the consensus of $0.81. Salesforce sees Q4 2022 revenue of $7.224-7.234 billion, versus the consensus of $7.22 billion.\nImmunoGen Inc. (Nasdaq: IMGN) 5.5% LOWER; intends to offer and sell, subject to market and other conditions, $175 million of shares of its common stock in an underwritten public offering.\nZscaler Inc. 4.6% HIGHER; reported Q1 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $230.5 million versus the consensus estimate of $208.43 million. Zscaler sees Q2 2022 EPS of $0.11, versus the consensus of $0.12. Zscaler sees Q2 2022 revenue of $240-242 million, versus the consensus of $221.15 million. Zscaler sees FY2022 EPS of $0.50-$0.52, versus the consensus of $0.56. Zscaler sees FY2022 revenue of $1-1.01 billion, versus the consensus of $0.94156 billion.\nHewlett Packard Enterprise 2.4% LOWER; reported Q4 EPS of $0.52, $0.03 better than the analyst estimate of $0.49. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $7.39 billion. Hewlett Packard Enterprise sees Q1 2022 EPS of $0.42-$0.50, versus the consensus of $0.49. Hewlett Packard Enterprise sees FY2022 EPS of $1.96-$2.10, versus the consensus of $2.03.\nNetApp 1.2% HIGHER; reported Q2 EPS of $1.28, $0.07 better than the analyst estimate of $1.21. Revenue for the quarter came in at $1.57 billion versus the consensus estimate of $1.55 billion. NetApp sees Q3 2022 EPS of $1.21-$1.31, versus the consensus of $1.28. NetApp sees Q3 2022 revenue of $1.53-1.68 billion, versus the consensus of $1.59 billion. NetApp sees FY2022 EPS of $4.90-$5.10, versus the consensus of $5.01.","news_type":1,"symbols_score_info":{"AMBA":0.9,"BOX":0.9,"CRM":0.9,"CTIC":0.9,"IMGN":0.9,"ZS":0.9}},"isVote":1,"tweetType":1,"viewCount":465,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/609495793"}
精彩评论